Hunan Dajiaweikang Pharmaceutical Industry Co Ltd - Class A

SZSE:301126 (China)   Class A
Â¥ 8.93 (+0.56%) Jun 21
47.00
P/B:
1.04
Market Cap:
Â¥ 1.84B ($ 253.96M)
Enterprise V:
Â¥ 4.54B ($ 624.38M)
Volume:
1.80M
Avg Vol (2M):
7.22M
Trade In:
Volume:
1.80M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Hunan Dajiaweikang Pharmaceutical Industry Co Ltd ( SZSE:301126 ) from 2021 to Jun 23 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Hunan Dajiaweikang Pharmaceutical Industry stock (SZSE:301126) PE ratio as of Jun 23 2024 is 47. More Details

Hunan Dajiaweikang Pharmaceutical Industry Co Ltd (SZSE:301126) PE Ratio (TTM) Chart

To

Hunan Dajiaweikang Pharmaceutical Industry Co Ltd (SZSE:301126) PE Ratio (TTM) Historical Data

Total 616
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Hunan Dajiaweikang Pharmaceutical Industry PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-23 47.0 2024-04-16 40.0
2024-06-21 47.0 2024-04-15 45.4
2024-06-20 46.7 2024-04-12 48.3
2024-06-19 48.0 2024-04-11 48.5
2024-06-18 48.2 2024-04-10 48.5
2024-06-17 47.2 2024-04-09 50.2
2024-06-14 47.6 2024-04-08 49.2
2024-06-13 48.3 2024-04-03 51.5
2024-06-12 49.4 2024-04-02 51.4
2024-06-11 47.9 2024-04-01 51.4
2024-06-07 48.2 2024-03-29 50.3
2024-06-06 46.0 2024-03-28 49.5
2024-06-05 50.6 2024-03-27 53.0
2024-06-04 51.5 2024-03-26 55.1
2024-06-03 49.6 2024-03-25 54.7
2024-05-31 51.3 2024-03-22 56.7
2024-05-30 51.0 2024-03-21 58.5
2024-05-29 51.4 2024-03-20 58.8
2024-05-28 51.3 2024-03-19 57.8
2024-05-27 51.9 2024-03-18 58.2
2024-05-24 51.3 2024-03-15 56.6
2024-05-23 51.6 2024-03-14 54.5
2024-05-22 55.6 2024-03-13 54.6
2024-05-21 52.6 2024-03-12 55.4
2024-05-20 53.2 2024-03-11 53.4
2024-05-17 53.1 2024-03-08 53.1
2024-05-16 52.4 2024-03-07 52.6
2024-05-15 53.3 2024-03-06 52.9
2024-05-14 55.2 2024-03-05 53.5
2024-05-13 54.2 2024-03-04 56.8
2024-05-10 58.3 2024-03-01 53.4
2024-05-09 65.0 2024-02-29 53.1
2024-05-08 54.2 2024-02-28 50.8
2024-05-07 53.6 2024-02-27 57.6
2024-05-06 52.0 2024-02-26 55.3
2024-04-30 50.2 2024-02-23 54.4
2024-04-29 49.6 2024-02-22 51.7
2024-04-26 47.3 2024-02-21 49.9
2024-04-25 47.4 2024-02-20 48.8
2024-04-24 46.5 2024-02-19 46.8
2024-04-23 45.8 2024-02-08 44.4
2024-04-22 42.5 2024-02-07 40.4
2024-04-19 42.5 2024-02-06 45.9
2024-04-18 42.8 2024-02-05 46.2
2024-04-17 43.7 2024-02-02 54.5

Hunan Dajiaweikang Pharmaceutical Industry Co Ltd (SZSE:301126) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Hunan Dajiaweikang Pharmaceutical Industry Co Ltd is engaged in the distribution and retail of pharmaceuticals, biological products, medical equipment and other products.